3D Printed Medicine Set to Offer The Industry $3.89 billion by 2022

A Rapid Increase in Medical 3D Printing

The relationship between 3D printing and the healthcare sector has been blossoming in recent years. A report has been published recently discussing market research into how 3D printing in the medical sector is going to develop in the near future. The 3D printing market is set to rise, and even cross the $3.89 billion mark by 2022. Patients are constantly being benefited by a variety of applications 3D printing has to offer, and this is a trend set to steadily rise as 3D printings prominence develops.

3D printing offers a level of customization and accuracy to patients that traditional manufacturing isn’t quite capable of. The technology is currently covering areas in medical, implants and drug manufacturing at a higher level of finish, and durability. 3D printing is offering medical solutions that weren’t possible several years ago. From facial reconstruction, to the development of 3D printed transplant organs like hearts, livers and even ears, to custom made prosthetic legs, the possibilities are endless and exciting to say the least!


The market is also able to cover an expansive amount of areas in medical manufacturing and offer new and precise solutions to these areas, something that is currently hard to achieve with current methods. Products and services, can cover the production of sometimes very complex materials, such metals, polymer, ceramic, and even human tissue, 3D printing allows for a more rapid and accurate production of these products.

Not only will 3D printing revolutionise and benefit the surgical and manufacturing sectors. We are going to see a dramatic difference in the current approach to medical testing in the pharmaceutical arena. With the launch of 3D printed organs, we are seeing an rapid decrease in the testing of new drugs, and medicine on animals. This is going to aid in a development of better and more ethical treatment of animals. Good news for our furry friends!

Again within the pharmaceutical sector we are seeing an advancement in the development of highly customised and patient specific drugs. 3D printers can create specifically designed medicine with accurate dosage size, colour and delivery modes which are are patient orientated and improve patient care.


The report makes for a very interesting read and as well as offering some valuable information in market research it also “gives a detailed and complete analysis of overall 3D printing healthcare market by geography across the regions such as North America, Europe, Middle-East & Africa, Asia-Pacific, and South America and further sub-segmented by countries.”

You can download the report here!